Zobrazeno 1 - 10
of 2 199
pro vyhledávání: '"Panjabi A"'
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 16, Pp 447-459 (2024)
Charles D Burger,1 Yuen Tsang,2 Marie Chivers,3 Riya Vijay Vekaria,3 Gurinderpal Doad,2,4 Nikki Atkins,3 Sumeet Panjabi2,4 1Division of Pulmonary Medicine, Mayo Clinic Florida, Jacksonville, FL, USA; 2Janssen Scientific Affiars, Titusville, NJ, USA;
Externí odkaz:
https://doaj.org/article/64fb536b652947f0ae975d999e3517a2
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 3, Pp n/a-n/a (2024)
Abstract Selexipag is an oral selective agonist of the prostacyclin receptor approved to treat adults with pulmonary arterial hypertension (PAH). Selexipag is initiated at a dose of 200 μg twice daily (bid) and usually titrated up by 200 μg bid wee
Externí odkaz:
https://doaj.org/article/ea14623c56694b43a0f9d5caea342257
Autor:
Harrison W. Farber, Hayley D. Germack, Nicole S. Croteau, Jason C. Simeone, Fei Tang, Carly J. Paoli, Gurinderpal Doad, Sumeet Panjabi, Teresa De Marco
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract Information on factors leading to pulmonary arterial hypertension (PAH) treatment discontinuation is limited. This study analyzed 12,902 new PAH medication users to identify predictors of treatment discontinuation. Treatment by accredited pu
Externí odkaz:
https://doaj.org/article/eb2cf11ab5fb414097686cac9796847e
Publikováno v:
The Clinical Respiratory Journal, Vol 17, Iss 12, Pp 1209-1222 (2023)
Abstract Background Oral selexipag, a prostacyclin pathway agent (PPA), is effective in patients with pulmonary arterial hypertension (PAH). The objective of this study is to assess the impact of initiating oral selexipag within 12 months of diagnosi
Externí odkaz:
https://doaj.org/article/6e90ef9b6af64431a304ddf7d0d0b8ba
Autor:
Pratiti J Gohil, Pankti Panchal, Gauri M. Panjabi, Jinal J. Gohil, Ushma H. Thakar, Raghav R. Rathi
Publikováno v:
Asian Journal of Medical Sciences, Vol 14, Iss 10, Pp 9-14 (2023)
Background: Ropivacaine, a new amino-amide local anesthetic agent, is similar in chemical structure to bupivacaine. The low solubility of ropivacaine leads to greater sensory-motor differentiation by blocking sensory nerve fiber more readily than mot
Externí odkaz:
https://doaj.org/article/a8becc01bd394b0fb76b59716b3dabc7
Autor:
Sharma, Deep S., Bariya, Sanjay N., Soni, Saurabh S., Patel, Nidhi N., Panjabi, Sanjay H., Patel, Vaibhav K.
Publikováno v:
In Materials Today Communications June 2024 39
Autor:
Surana, Karan, Panjabi, Sanjay H., Varade, Dharmesh, Deshpande, M.P., Deshpande, Uday P., Soni, Saurabh S.
Publikováno v:
In Applied Materials Today February 2024 36
Publikováno v:
Nature Environment and Pollution Technology, Vol 22, Iss 3, Pp 1555-1562 (2023)
In view of the environmental problems generated by the large-scale production of fly ash, increasing attention is now being paid to the recycling of fly ash as a good source of nutrients. To reduce the cost of fly ash disposal and best utilization, i
Externí odkaz:
https://doaj.org/article/584cfb372ace450ca604ddda851ab023
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 7 (2024)
Externí odkaz:
https://doaj.org/article/2b66f2b579364a53aa1c7aecadb21f48
Autor:
Bernath-Plaisted, Jacy S., Correll, Maureen D., Somershoe, Scott G., Dwyer, Angela M., Bankert, Andy, Beh, Adam, Berlanga, Humberto, Boyle, W. Alice, Cruz-Romo, J. Lizardo, George, T. Luke, Herkert, James, Koper, Nicola, Macías-Duarte, Alberto, Panjabi, Arvind O., Ramírez-Flores, Oscar M., Robinson, Barry, Ruvalcaba-Ortega, Irene, Sibbing, Julie, Strasser, Erin H., Titulaer, Mieke, Van Pelt, William E., VerCauteren, Tammy
Publikováno v:
In Rangeland Ecology & Management September 2023 90:165-185